Your session is about to expire
← Back to Search
SOC + POC (Portable Oxygen Concentrator) for Chronic Obstructive Pulmonary Disease (POC-STEP Trial)
N/A
Waitlist Available
Research Sponsored by ResMed
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Summary
This trial will compare the effects of portable oxygen concentrators combined with standard care versus standard care alone on activity and other measures in COPD patients who require continuous long-term oxygen therapy.
Eligible Conditions
- Chronic Obstructive Pulmonary Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physical Activity Level
Secondary outcome measures
Hospital Anxiety and Depression Scale (HADS): Anxiety
Oxygen Usage
St. George Respiratory Questionnaire (SGRQ)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SOC + POC (Portable Oxygen Concentrator)Experimental Treatment1 Intervention
Standard of care long-term oxygen therapy + POC
Group II: Standard Of Care (SOC)Active Control1 Intervention
Standard of care long-term oxygen therapy
Find a Location
Who is running the clinical trial?
Inogen Inc.Industry Sponsor
3 Previous Clinical Trials
61 Total Patients Enrolled
ResMedLead Sponsor
135 Previous Clinical Trials
47,790 Total Patients Enrolled
MaryKay SobcinskiStudy ChairRCRI
Share this study with friends
Copy Link
Messenger